Study of the Safety and Efficacy of Cefdinir and Levofloxacin for the Treatment of Subjects With Acute Bacterial Sinusitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of a ten-day course of therapy of cefdinir, 600 mg QD, to
a ten-day course of therapy of levofloxacin, 500 mg QD, in the treatment of acute bacterial
sinusitis.